Intra-Cellular Therapies Inc. (ITCI): Price and Financial Metrics
ITCI Price/Volume Stats
| Current price | $83.45 | 52-week high | $93.45 |
| Prev. close | $84.14 | 52-week low | $62.78 |
| Day low | $82.76 | Volume | 1,120,400 |
| Day high | $85.03 | Avg. volume | 827,488 |
| 50-day MA | $83.42 | Dividend yield | N/A |
| 200-day MA | $74.66 | Market Cap | 8.85B |
ITCI Stock Price Chart Interactive Chart >
Intra-Cellular Therapies Inc. (ITCI) Company Bio
Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson's and Alzheimer's disease. The company was founded in 2002 and is based in New York, New York.
ITCI Price Returns
| 1-mo | -2.34% |
| 3-mo | 7.52% |
| 6-mo | 10.43% |
| 1-year | 18.62% |
| 3-year | 67.87% |
| 5-year | 128.57% |
| YTD | 16.52% |
| 2023 | 35.34% |
| 2022 | 1.11% |
| 2021 | 64.59% |
| 2020 | -7.32% |
| 2019 | 201.23% |
Loading social stream, please wait...